Yoshimasa Ito Selected Research

Brain Ischemia (Cerebral Ischemia)

1/2018	An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats.
12/2015	Intravenous Administration of Cilostazol Nanoparticles Ameliorates Acute Ischemic Stroke in a Cerebral Ischemia/Reperfusion-Induced Injury Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshimasa Ito Research Topics

Disease

27	Cataract (Cataracts) 01/2017 - 10/2002
10	Arthritis (Polyarthritis) 01/2017 - 10/2007
9	Rheumatoid Arthritis 01/2017 - 01/2009
8	Type 2 Diabetes Mellitus (MODY) 03/2016 - 01/2009
7	Inflammation (Inflammations) 10/2016 - 10/2007
7	Glaucoma 03/2015 - 01/2010
6	Wounds and Injuries (Trauma) 01/2015 - 05/2009
6	Corneal Injuries 01/2015 - 09/2009
6	Body Weight (Weight, Body) 01/2015 - 01/2009
5	Diabetes Mellitus 01/2015 - 01/2009
4	Hyperglycemia 03/2016 - 01/2010
4	Edema (Dropsy) 01/2015 - 10/2007
3	Cerebral Infarction 04/2018 - 05/2008
3	Uveitis 02/2012 - 10/2010
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 12/2015
2	Ischemic Stroke 01/2018 - 12/2015
2	Adenocarcinoma of Lung 02/2016 - 01/2014
2	Adenocarcinoma 02/2016 - 01/2014
2	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 01/2015
2	Ocular Hypertension (Glaucoma, Suspect) 01/2013 - 01/2010
2	Optic Nerve Injuries 07/2009 - 05/2008
1	Acute Lung Injury 10/2023
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2023
1	Epilepsy (Aura) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Ataxia (Dyssynergia) 01/2023
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Pain (Aches) 01/2022
1	Nephritis 09/2021
1	Acute Kidney Injury (Acute Renal Failure) 09/2021

Drug/Important Bio-Agent (IBA)

19	Ophthalmic Solutions (Eye Drops)IBA 01/2017 - 07/2004
12	Disulfiram (Antabuse)FDA Link 01/2015 - 02/2003
9	MagnesiumIBA 01/2017 - 01/2006
9	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2009
8	Messenger RNA (mRNA)IBA 02/2016 - 04/2004
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 11/2007
7	Indomethacin (Indometacin)FDA LinkGeneric 01/2017 - 01/2009
7	SolutionsIBA 03/2015 - 08/2007
6	SuspensionsIBA 01/2017 - 10/2007
6	Adenosine Triphosphate (ATP)IBA 01/2017 - 04/2004
6	Proteins (Proteins, Gene)FDA Link 02/2016 - 02/2003
6	Interleukin-18 (Interleukin 18)IBA 01/2016 - 11/2007
6	Adenosine Triphosphatases (ATPase)IBA 01/2016 - 12/2007
5	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2015 - 07/2004
4	Cilostazol (Pletal)FDA LinkGeneric 04/2018 - 05/2008
4	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2017 - 12/2007
4	CalciumIBA 01/2016 - 01/2007
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015 - 01/2009
4	Sericins (Sericin)IBA 12/2013 - 05/2009
4	Triglycerides (Triacylglycerol)IBA 01/2013 - 01/2009
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2011 - 02/2003
4	2-Hydroxypropyl-beta-cyclodextrinIBA 01/2010 - 07/2004
4	pimagedine (aminoguanidine)IBA 11/2008 - 02/2003
3	Therapeutic UsesIBA 01/2023 - 01/2014
3	EnzymesIBA 12/2018 - 01/2014
3	Amyloid (Amyloid Fibrils)IBA 03/2016 - 01/2014
3	Methylcellulose (BFL)IBA 12/2015 - 01/2012
3	HCEIBA 01/2015 - 01/2011
3	Hypromellose DerivativesIBA 01/2015 - 01/2010
3	Timolol (Blocadren)FDA LinkGeneric 01/2015 - 01/2011
3	Ointments (Pastes)IBA 01/2015 - 01/2014
3	Drinking WaterIBA 01/2014 - 06/2006
3	CholesterolIBA 01/2013 - 01/2009
3	EndotoxinsIBA 02/2012 - 10/2010
2	Immune Checkpoint InhibitorsIBA 01/2022 - 09/2021
2	pembrolizumabIBA 01/2022 - 09/2021
2	IpilimumabIBA 01/2022 - 09/2021
2	NivolumabIBA 01/2022 - 09/2021
2	Lipase (Acid Lipase)FDA Link 02/2016 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 02/2016 - 01/2014
2	InterleukinsIBA 01/2016 - 01/2015
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2016 - 05/2008
2	Sweetening Agents (Sweeteners)IBA 01/2015 - 01/2013
2	Antiglaucoma AgentsIBA 01/2015 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2006
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2014 - 01/2011
2	Insulin (Novolin)FDA Link 01/2013 - 01/2009
2	InterferonsIBA 01/2013 - 06/2011
2	CyclodextrinsIBA 02/2012 - 07/2004
2	Latanoprost (Xalatan)FDA Link 01/2011 - 01/2010
2	Travoprost (Travatan)FDA Link 01/2011 - 01/2010
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2010 - 05/2008
2	AntioxidantsIBA 01/2009 - 02/2003
2	Lipid PeroxidesIBA 05/2008 - 05/2008
2	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 10/2004 - 02/2003
2	Selenious Acid (Selenite)IBA 07/2004 - 02/2003
1	FibrinIBA 10/2023
1	Protein Glutamine gamma Glutamyltransferase 2IBA 10/2023
1	Histones (Histone)IBA 10/2023
1	perampanelIBA 01/2023
1	durvalumabIBA 09/2021
1	Proton Pump InhibitorsIBA 09/2021
1	Omeprazole (Prilosec)FDA LinkGeneric 09/2021

Therapy/Procedure

15	Lenses 03/2016 - 02/2003
12	Therapeutics 12/2016 - 10/2007
6	Oral Administration 01/2018 - 10/2007
1	Induced Hyperthermia (Thermotherapy) 01/2023